Login
Home / AYTU : NASDAQ
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Aytu BioPharma, Inc.

$2 -$0.77 (-27.80%)
NASDAQ · 14 Sep 2026 20:00 UTC
Previous Close
$1.99
Day Range
$1.95$2.09
Year Range
$1.65$3.07
Market Cap
21.47M
AVG Volume
33.73K
Trailing/Forward PE
-0.47/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-09-22
Primary Exchange
NASDAQUS
Revenue (USD)
050M100M150M2016201720182019202020212022202320242025
Net Income (USD)
-150M-100M-50M02016201720182019202020212022202320242025
Operating Income (USD)
-150M-100M-50M02016201720182019202020212022202320242025
EBITDA (USD)
-30M-20M-10M02016201720182019202020212022202320242025
Cash Flows (USD)
-30M-20M-10M02016201720182019202020212022202320242025
EPS (USD)
-1500000-1000000-50000002016201720182019202020212022202320242025
Expenses (USD)
-25M025M50M75M100MR&DSG&ACapex2016201720182019202020212022202320242025
Cash & Debt (USD)
020M40M60MCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
Debt ratios
-0.2500.250.50.75120182019202020212022202320242025
Margins
0%20%40%60%80%2016201720182019202020212022202320242025
Return on Capital
-600%-400%-200%0%2016201720182019202020212022202320242025
Shares Outstanding
02M4M6M8M2016201720182019202020212022202320242025
Book Value Per Share (USD)
01000002000003000002016201720182019202020212022202320242025
Total Assets (USD)
0100M200M300M2016201720182019202020212022202320242025
Employee Count
0501001502002016201720182019202020212022202320242025
PE Ratio
678910med 8.27May 25Jun 25Jun 25Jul 25Aug 25Aug 25Sep 25
Free Cash Flow Yield
-60%-40%-20%0%20%med -5.99%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Sales
00.10.20.30.40.5med 0.21Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EV/EBITDA
1.522.533.5med 2.82Jun 24Aug 24Dec 24Feb 25May 25Jul 25Sep 25
Price/Operating Cashflow
051015med 3.74Jan 24Apr 24Jun 24Sep 24Apr 25Jun 26Sep 26
Price to Book
00.511.52med 0.61Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Aytu BioPharma, Inc.
AYTU
Stockpicker

Video analysis: AYTU

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: AYTU

AWM Investment Company Inc. Invests $1.33 Million in Aytu BioPharma Inc. $AYTU

defenseworld.net · 26 Aug 2026

AWM Investment Company Inc. Invests $1.33 Million in Aytu BioPharma Inc. $AYTU

AWM Investment Company Inc. bought a new stake in Aytu BioPharma Inc. (NASDAQ: AYTU) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 619,574 shares of the company's stock, valued at approximately $1,332,000. AWM Investment Company Inc. owned
New Strong Sell Stocks for July 20th

zacks.com · 20 Jul 2026

New Strong Sell Stocks for July 20th

ACR, AEM and AYTU have been added to the Zacks Rank #5 (Strong Sell) List on July 20, 2026.
New Strong Sell Stocks for July 16th

zacks.com · 16 Jul 2026

New Strong Sell Stocks for July 16th

AYTU, CAMP and CRC have been added to the Zacks Rank #5 (Strong Sell) List on July 16, 2026.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.